O	O	0	10	Engagement	Engagement	B-NP	NN	O	10	SUB	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	14	17	the	the	B-NP	DT	O	6	NMOD	O
O	O	18	23	Lewis	Lewis	I-NP	NNP	O	6	NMOD	O
O	O	24	25	X	X	I-NP	NN	O	6	NMOD	O
O	O	26	33	antigen	antigen	I-NP	NN	O	2	PMOD	O
O	O	34	35	(	(	O	(	O	9	DEP	O
O	O	35	39	CD15	CD15	B-NP	NN	B-protein	9	DEP	B-protein
O	O	39	40	)	)	O	)	O	6	NMOD	O
O	O	41	48	results	result	B-VP	VBZ	O	0	ROOT	O
O	O	49	51	in	in	B-PP	IN	O	10	VMOD	O
O	O	52	60	monocyte	monocyte	B-NP	NN	O	13	NMOD	O
O	O	61	71	activation	activation	I-NP	NN	O	11	PMOD	O
O	O	71	72	.	.	O	.	O	10	P	O

O	O	74	76	We	We	B-NP	PRP	O	3	SUB	O
O	O	77	87	previously	previously	B-ADVP	RB	O	3	VMOD	O
O	O	88	96	reported	report	B-VP	VBD	O	0	ROOT	O
O	O	97	101	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	102	110	monocyte	monocyte	B-NP	NN	O	6	NMOD	O
O	O	111	119	adhesion	adhesion	I-NP	NN	O	22	SUB	O
O	O	120	122	to	to	B-PP	TO	O	6	NMOD	O
T1	B-Protein	123	128	tumor	tumor	B-NP	NN	B-protein	12	NMOD	B-protein
T1	I-Protein	129	137	necrosis	necrosis	I-NP	NN	I-protein	12	NMOD	I-protein
T1	I-Protein	138	144	factor	factor	I-NP	NN	I-protein	12	NMOD	I-protein
T1	I-Protein	144	145	-	-	O	HYPH	I-protein	12	P	I-protein
T1	I-Protein	145	150	alpha	alpha	B-NP	SYM	I-protein	16	NMOD	I-protein
O	O	151	152	(	(	O	(	O	16	NMOD	O
T2	B-Protein	152	155	TNF	TNF	B-NP	NN	B-protein	16	NMOD	B-protein
T2	I-Protein	155	156	-	-	O	HYPH	O	16	P	O
T2	I-Protein	156	161	alpha	alpha	B-NP	SYM	O	21	NMOD	O
O	O	161	162	)	)	O	)	O	16	AMOD	O
O	O	162	163	-	-	B-NP	HYPH	O	21	NMOD	O
O	O	163	170	treated	treat	I-NP	VBN	O	21	NMOD	O
O	O	171	182	endothelial	endothelial	I-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	183	188	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	189	198	increased	increase	B-VP	VBD	O	4	SBAR	O
O	O	199	209	expression	expression	B-NP	NN	O	22	OBJ	O
O	O	210	212	of	of	B-PP	IN	O	23	NMOD	O
T3	B-Protein	213	219	tissue	tissue	B-NP	NN	B-protein	26	NMOD	B-protein
T3	I-Protein	220	226	factor	factor	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	227	230	and	and	O	CC	O	28	NMOD	O
T4	B-Protein	231	235	CD36	CD36	B-NP	NN	B-protein	24	PMOD	B-protein
O	O	236	238	on	on	B-PP	IN	O	23	NMOD	O
O	O	239	248	monocytes	monocyte	B-NP	NNS	B-cell_type	29	PMOD	B-cell_type
O	O	248	249	.	.	O	.	O	3	P	O

O	O	250	255	Using	Use	B-VP	VBG	O	16	VMOD	O
O	O	256	269	immunological	immunological	B-ADJP	JJ	B-protein	1	OBJ	B-protein
O	O	270	275	cross	cross	O	AFX	I-protein	2	AMOD	I-protein
O	O	275	276	-	-	O	HYPH	O	3	P	O
O	O	276	283	linking	link	B-VP	VBG	O	3	NMOD	O
O	O	284	286	to	to	B-PP	TO	O	5	VMOD	O
O	O	287	292	mimic	mimic	B-NP	JJ	O	9	NMOD	O
O	O	293	301	receptor	receptor	I-NP	NN	O	9	NMOD	O
O	O	302	312	engagement	engagement	I-NP	NN	O	6	PMOD	O
O	O	313	315	by	by	B-PP	IN	O	9	NMOD	O
O	O	316	323	natural	natural	B-NP	JJ	O	12	NMOD	O
O	O	324	331	ligands	ligand	I-NP	NNS	O	10	PMOD	O
O	O	331	332	,	,	O	,	O	16	P	O
O	O	333	335	we	we	B-NP	PRP	O	16	SUB	O
O	O	336	339	now	now	B-ADVP	RB	O	16	VMOD	O
O	O	340	344	show	show	B-VP	VBP	O	0	ROOT	O
O	O	345	349	that	that	B-SBAR	IN	O	16	VMOD	O
O	O	350	354	CD15	CD15	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	355	356	(	(	O	(	O	22	DEP	O
O	O	356	361	Lewis	Lewis	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	362	363	X	X	I-NP	NN	I-protein	22	DEP	I-protein
O	O	363	364	)	)	O	)	O	18	NMOD	O
O	O	364	365	,	,	O	,	O	25	P	O
O	O	366	367	a	a	B-NP	DT	O	25	NMOD	O
O	O	368	376	monocyte	monocyte	I-NP	NN	B-protein	32	SUB	B-protein
O	O	377	384	counter	counter	O	AFX	I-protein	28	NMOD	I-protein
O	O	384	385	-	-	O	HYPH	I-protein	28	P	I-protein
O	O	385	393	receptor	receptor	B-NP	NN	I-protein	25	NMOD	I-protein
O	O	394	397	for	for	B-PP	IN	O	25	NMOD	O
T5	B-Protein	398	409	endothelial	endothelial	B-NP	JJ	B-protein	31	NMOD	B-protein
T5	I-Protein	410	419	selectins	selectin	I-NP	NNS	I-protein	29	PMOD	I-protein
O	O	420	423	may	may	B-VP	MD	O	17	SBAR	O
O	O	424	435	participate	participate	I-VP	VB	O	32	VC	O
O	O	436	438	in	in	B-PP	IN	O	33	VMOD	O
O	O	439	443	this	this	B-NP	DT	O	36	NMOD	O
O	O	444	452	response	response	I-NP	NN	O	34	PMOD	O
O	O	452	453	.	.	O	.	O	16	P	O

O	O	454	456	We	We	B-NP	PRP	O	2	SUB	O
O	O	457	461	used	use	B-VP	VBD	O	0	ROOT	O
O	O	462	470	cytokine	cytokine	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	471	481	production	production	I-NP	NN	O	2	OBJ	O
O	O	482	484	as	as	B-PP	IN	O	2	VMOD	O
O	O	485	486	a	a	B-NP	DT	O	7	NMOD	O
O	O	487	494	readout	readout	I-NP	NN	O	5	PMOD	O
O	O	495	498	for	for	B-PP	IN	O	7	NMOD	O
O	O	499	507	monocyte	monocyte	B-NP	NN	O	10	NMOD	O
O	O	508	518	activation	activation	I-NP	NN	O	8	PMOD	O
O	O	519	522	and	and	O	CC	O	2	VMOD	O
O	O	523	528	found	find	B-VP	VBD	O	2	VMOD	O
O	O	529	533	that	that	B-SBAR	IN	O	12	VMOD	O
O	O	534	538	CD15	CD15	B-NP	NN	B-protein	13	SBAR	B-protein
O	O	539	544	cross	cross	O	AFX	O	14	NMOD	O
O	O	544	545	-	-	O	HYPH	O	15	P	O
O	O	545	552	linking	link	B-VP	VBG	O	15	VMOD	O
O	O	553	560	induced	induce	B-NP	VBN	O	22	NMOD	O
T6	B-Protein	561	564	TNF	TNF	I-NP	NN	B-protein	22	NMOD	B-protein
T6	I-Protein	564	565	-	-	O	HYPH	O	22	NMOD	O
T6	I-Protein	565	570	alpha	alpha	B-NP	SYM	O	22	NMOD	O
O	O	571	578	release	release	I-NP	NN	O	17	OBJ	O
O	O	579	583	from	from	B-PP	IN	O	22	NMOD	O
O	O	584	594	peripheral	peripheral	B-NP	JJ	B-cell_type	26	NMOD	B-cell_type
O	O	595	600	blood	blood	I-NP	NN	I-cell_type	26	NMOD	I-cell_type
O	O	601	610	monocytes	monocyte	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	611	614	and	and	I-NP	CC	O	17	VMOD	O
O	O	615	620	cells	cell	I-NP	NNS	O	17	OBJ	O
O	O	621	625	from	from	B-PP	IN	O	28	NMOD	O
O	O	626	629	the	the	B-NP	DT	O	34	NMOD	O
O	O	630	639	monocytic	monocytic	I-NP	JJ	B-cell_line	34	NMOD	B-cell_line
O	O	640	644	cell	cell	I-NP	NN	I-cell_line	34	NMOD	I-cell_line
O	O	645	649	line	line	I-NP	NN	I-cell_line	34	NMOD	I-cell_line
O	O	650	653	MM6	MM6	I-NP	NN	I-cell_line	29	PMOD	I-cell_line
O	O	653	654	.	.	O	.	O	2	P	O

O	O	655	667	Quantitative	Quantitative	B-NP	JJ	O	7	NMOD	O
O	O	668	675	reverse	reverse	I-NP	JJ	B-protein	3	NMOD	B-protein
O	O	676	689	transcriptase	transcriptase	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	689	690	-	-	I-NP	HYPH	O	7	NMOD	O
O	O	690	700	polymerase	polymerase	I-NP	NN	O	7	NMOD	O
O	O	701	706	chain	chain	I-NP	NN	O	7	NMOD	O
O	O	707	715	reaction	reaction	I-NP	NN	O	13	SUB	O
O	O	716	717	(	(	O	(	O	12	DEP	O
O	O	717	719	RT	RT	B-NP	NN	O	11	NMOD	O
O	O	719	720	-	-	B-NP	HYPH	O	11	P	O
O	O	720	723	PCR	PCR	I-NP	NN	O	12	DEP	O
O	O	723	724	)	)	O	)	O	7	NMOD	O
O	O	725	731	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	732	734	an	an	B-NP	DT	O	15	NMOD	O
O	O	735	743	increase	increase	I-NP	NN	O	13	OBJ	O
O	O	744	746	in	in	B-PP	IN	O	15	NMOD	O
O	O	747	753	steady	steady	B-NP	JJ	O	23	NMOD	O
O	O	753	754	-	-	I-NP	HYPH	O	23	P	O
O	O	754	759	state	state	I-NP	NN	O	23	NMOD	O
T7	B-Protein	760	763	TNF	TNF	I-NP	NN	B-protein	23	NMOD	B-protein
T7	I-Protein	763	764	-	-	I-NP	HYPH	O	23	P	O
T7	I-Protein	764	769	alpha	alpha	I-NP	NN	B-RNA	23	NMOD	B-RNA
O	O	770	774	mRNA	mRNA	I-NP	NN	I-RNA	16	PMOD	I-RNA
O	O	775	780	after	after	B-PP	IN	O	13	VMOD	O
O	O	781	782	3	3	B-NP	CD	O	27	AMOD	O
O	O	783	785	to	to	I-NP	TO	O	27	AMOD	O
O	O	786	787	4	4	I-NP	CD	O	28	NMOD	O
O	O	788	793	hours	hour	I-NP	NNS	O	24	PMOD	O
O	O	794	796	of	of	B-PP	IN	O	28	NMOD	O
O	O	797	802	cross	cross	B-NP	AFX	O	29	PMOD	O
O	O	802	803	-	-	I-NP	HYPH	O	30	P	O
O	O	803	810	linking	link	B-VP	VBG	O	30	NMOD	O
O	O	810	811	.	.	O	.	O	13	P	O

O	O	812	816	CD15	CD15	B-NP	NN	B-protein	7	SUB	B-protein
O	O	817	822	cross	cross	O	AFX	O	7	VMOD	O
O	O	822	823	-	-	O	HYPH	O	2	P	O
O	O	823	830	linking	link	B-VP	VBG	O	7	SUB	O
O	O	831	835	also	also	B-ADVP	RB	O	4	VMOD	O
O	O	836	849	concomitantly	concomitantly	B-ADVP	RB	O	4	VMOD	O
O	O	850	859	increased	increase	B-VP	VBD	O	0	ROOT	O
T8	B-Protein	860	871	interleukin	interleukin	B-NP	NN	B-RNA	18	NMOD	B-RNA
T8	I-Protein	871	872	-	-	O	HYPH	I-RNA	18	P	I-RNA
T8	I-Protein	872	873	1	1	B-NP	CD	I-RNA	11	NMOD	I-RNA
T8	I-Protein	874	878	beta	beta	I-NP	NN	I-RNA	18	NMOD	I-RNA
O	O	879	880	(	(	O	(	I-RNA	18	NMOD	I-RNA
T9	B-Protein	880	882	IL	IL	B-NP	NN	I-RNA	18	NMOD	I-RNA
T9	I-Protein	882	883	-	-	O	HYPH	I-RNA	13	P	I-RNA
T9	I-Protein	883	884	1	1	O	CD	I-RNA	18	NMOD	I-RNA
T9	I-Protein	885	889	beta	beta	O	SYM	I-RNA	17	DEP	I-RNA
O	O	889	890	)	)	O	)	I-RNA	18	NMOD	I-RNA
O	O	891	895	mRNA	mRNA	B-NP	NN	I-RNA	7	OBJ	I-RNA
O	O	895	896	,	,	O	,	O	7	P	O
O	O	897	902	while	while	B-SBAR	IN	O	7	VMOD	O
O	O	903	905	no	no	B-NP	DT	O	23	NMOD	O
O	O	906	914	apparent	apparent	I-NP	JJ	O	23	NMOD	O
O	O	915	921	change	change	I-NP	NN	O	24	SUB	O
O	O	922	925	was	be	B-VP	VBD	O	20	SBAR	O
O	O	926	934	observed	observe	I-VP	VBN	O	24	VC	O
O	O	935	937	in	in	B-PP	IN	O	25	VMOD	O
O	O	938	941	the	the	B-NP	DT	O	28	NMOD	O
O	O	942	948	levels	level	I-NP	NNS	O	26	PMOD	O
O	O	949	951	of	of	B-PP	IN	O	28	NMOD	O
T10	B-Protein	952	956	beta	beta	B-NP	SYM	B-RNA	33	NMOD	B-RNA
T10	I-Protein	956	957	-	-	B-NP	HYPH	I-RNA	33	NMOD	I-RNA
T10	I-Protein	957	962	actin	actin	I-NP	NN	I-RNA	33	NMOD	I-RNA
O	O	963	967	mRNA	mRNA	I-NP	NN	I-RNA	29	PMOD	I-RNA
O	O	967	968	,	,	O	,	O	24	P	O
O	O	969	979	indicating	indicate	B-VP	VBG	O	24	VMOD	O
O	O	980	991	specificity	specificity	B-NP	NN	O	35	OBJ	O
O	O	991	992	.	.	O	.	O	7	P	O

O	O	993	995	To	To	B-VP	TO	O	2	VMOD	O
O	O	996	1003	examine	examine	I-VP	VB	O	26	VMOD	O
O	O	1004	1019	transcriptional	transcriptional	B-NP	JJ	O	4	NMOD	O
O	O	1020	1030	regulation	regulation	I-NP	NN	O	2	OBJ	O
O	O	1031	1033	of	of	B-PP	IN	O	4	NMOD	O
T16	B-Entity	1034	1042	cytokine	cytokine	B-NP	NN	B-DNA	7	NMOD	B-DNA
T16	I-Entity	1043	1048	genes	gene	I-NP	NNS	I-DNA	5	PMOD	I-DNA
O	O	1049	1051	by	by	B-PP	IN	O	4	NMOD	O
O	O	1052	1056	CD15	CD15	B-NP	NN	B-protein	10	NMOD	B-protein
O	O	1057	1067	engagement	engagement	I-NP	NN	O	8	PMOD	O
O	O	1067	1068	,	,	O	,	O	26	P	O
O	O	1069	1070	a	a	B-NP	DT	O	16	NMOD	O
T11	B-Protein	1071	1074	CAT	CAT	I-NP	NN	B-DNA	16	NMOD	B-DNA
O	O	1075	1082	plasmid	plasmid	I-NP	NN	I-DNA	16	NMOD	I-DNA
O	O	1083	1091	reporter	reporter	I-NP	NN	I-DNA	16	NMOD	I-DNA
O	O	1092	1101	construct	construct	I-NP	NN	I-DNA	26	SUB	I-DNA
O	O	1102	1112	containing	contain	B-VP	VBG	O	16	NMOD	O
T12	B-Protein	1113	1115	IL	IL	B-NP	NN	B-DNA	25	NMOD	B-DNA
T12	I-Protein	1115	1116	-	-	O	HYPH	I-DNA	25	NMOD	I-DNA
T12	I-Protein	1116	1117	1	1	B-NP	CD	I-DNA	25	NMOD	I-DNA
T12	I-Protein	1118	1122	beta	beta	I-NP	SYM	I-DNA	25	NMOD	I-DNA
T17	B-Entity	1123	1131	promoter	promoter	I-NP	NN	I-DNA	25	NMOD	I-DNA
T17	I-Entity	1131	1132	/	/	B-NP	SYM	O	25	NMOD	O
T17	I-Entity	1132	1140	enhancer	enhancer	B-NP	NN	B-DNA	25	NMOD	B-DNA
T17	I-Entity	1141	1150	sequences	sequence	I-NP	NNS	I-DNA	17	OBJ	I-DNA
O	O	1151	1154	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1155	1165	introduced	introduce	I-VP	VBN	O	26	VC	O
O	O	1166	1170	into	into	B-PP	IN	O	27	VMOD	O
O	O	1171	1174	MM6	MM6	B-NP	NN	B-cell_line	28	PMOD	B-cell_line
O	O	1174	1175	.	.	O	.	O	26	P	O

O	O	1176	1186	Subsequent	Subsequent	O	JJ	O	0	ROOT	O
O	O	1187	1192	cross	cross	O	AFX	O	1	VMOD	O
O	O	1192	1193	-	-	O	HYPH	O	2	VMOD	O
O	O	1193	1200	linking	link	B-VP	VBG	O	3	NMOD	O
O	O	1201	1203	of	of	B-PP	IN	O	4	VMOD	O
O	O	1204	1208	CD15	CD15	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	1209	1218	increased	increase	B-VP	VBD	O	3	VMOD	O
T13	B-Protein	1219	1222	CAT	CAT	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	1223	1231	activity	activity	I-NP	NN	O	7	OBJ	O
O	O	1231	1232	.	.	O	.	O	1	P	O

O	O	1233	1237	CD15	CD15	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	1238	1248	engagement	engagement	I-NP	NN	O	7	SUB	O
O	O	1249	1251	by	by	B-PP	IN	O	2	NMOD	O
O	O	1252	1262	monoclonal	monoclonal	B-NP	JJ	B-protein	5	NMOD	B-protein
O	O	1263	1271	antibody	antibody	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	1272	1276	also	also	B-ADVP	RB	O	7	VMOD	O
O	O	1277	1287	attenuated	attenuate	B-VP	VBD	O	0	ROOT	O
T14	B-Protein	1288	1290	IL	IL	B-NP	NN	B-protein	12	NMOD	B-protein
T14	I-Protein	1290	1291	-	-	O	HYPH	I-protein	12	NMOD	I-protein
T14	I-Protein	1291	1292	1	1	B-NP	CD	I-protein	12	NMOD	I-protein
T14	I-Protein	1293	1297	beta	beta	I-NP	SYM	I-protein	12	NMOD	I-protein
O	O	1298	1308	transcript	transcript	I-NP	NN	O	13	NMOD	O
O	O	1309	1320	degradation	degradation	I-NP	NN	O	7	OBJ	O
O	O	1320	1321	,	,	O	,	O	7	P	O
O	O	1322	1335	demonstrating	demonstrate	B-VP	VBG	O	7	VMOD	O
O	O	1336	1340	that	that	B-SBAR	IN	O	15	VMOD	O
O	O	1341	1350	signaling	signaling	B-NP	NN	O	21	SUB	O
O	O	1351	1354	via	via	B-PP	IN	O	17	NMOD	O
O	O	1355	1359	CD15	CD15	B-NP	NN	B-protein	18	PMOD	B-protein
O	O	1360	1364	also	also	B-ADVP	RB	O	21	VMOD	O
O	O	1365	1368	had	have	B-VP	VBD	O	16	SBAR	O
O	O	1369	1388	posttranscriptional	posttranscriptional	B-NP	JJ	O	23	NMOD	O
O	O	1389	1396	effects	effect	I-NP	NNS	O	21	OBJ	O
O	O	1396	1397	.	.	O	.	O	7	P	O

O	O	1398	1405	Nuclear	Nuclear	B-NP	JJ	O	2	NMOD	O
O	O	1406	1414	extracts	extract	I-NP	NNS	O	10	NMOD	O
O	O	1415	1417	of	of	B-PP	IN	O	2	NMOD	O
O	O	1418	1422	anti	anti	B-NP	AFX	O	6	NMOD	O
O	O	1422	1423	-	-	I-NP	HYPH	O	6	NMOD	O
O	O	1423	1427	CD15	CD15	I-NP	NN	B-protein	3	PMOD	B-protein
O	O	1428	1433	cross	cross	O	AFX	O	10	NMOD	O
O	O	1433	1434	-	-	O	HYPH	B-cell_type	10	NMOD	B-cell_type
O	O	1434	1440	linked	link	B-NP	VBN	I-cell_type	10	NMOD	I-cell_type
O	O	1441	1446	cells	cell	I-NP	NNS	I-cell_type	11	SUB	I-cell_type
O	O	1447	1459	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	O
O	O	1460	1468	enhanced	enhance	B-NP	VBN	O	13	NMOD	O
O	O	1469	1475	levels	level	I-NP	NNS	O	11	OBJ	O
O	O	1476	1478	of	of	B-PP	IN	O	13	NMOD	O
O	O	1479	1482	the	the	B-NP	DT	O	19	NMOD	O
T18	B-Entity	1483	1498	transcriptional	transcriptional	I-NP	JJ	B-protein	19	NMOD	B-protein
T18	I-Entity	1499	1505	factor	factor	I-NP	NN	I-protein	19	NMOD	I-protein
T18	I-Entity	1506	1515	activator	activator	I-NP	NN	I-protein	19	NMOD	I-protein
T18	I-Entity	1516	1523	protein	protein	I-NP	NN	I-protein	14	PMOD	I-protein
T18	I-Entity	1523	1524	-	-	B-NP	HYPH	O	19	P	O
T18	I-Entity	1524	1525	1	1	I-NP	CD	O	19	NMOD	O
O	O	1525	1526	,	,	O	,	O	11	P	O
O	O	1527	1536	minimally	minimally	B-ADVP	RB	O	24	VMOD	O
O	O	1537	1544	changed	change	B-VP	VBD	O	11	VMOD	O
T19	B-Entity	1545	1552	nuclear	nuclear	B-NP	JJ	B-protein	29	NMOD	B-protein
T19	I-Entity	1553	1559	factor	factor	I-NP	NN	I-protein	29	NMOD	I-protein
T19	I-Entity	1559	1560	-	-	B-NP	HYPH	I-protein	29	NMOD	I-protein
T19	I-Entity	1560	1565	kappa	kappa	I-NP	NN	I-protein	29	NMOD	I-protein
T19	I-Entity	1566	1567	B	B	I-NP	NN	I-protein	24	OBJ	I-protein
O	O	1567	1568	,	,	O	,	O	11	P	O
O	O	1569	1572	and	and	O	CC	O	11	VMOD	O
O	O	1573	1576	did	do	B-VP	VBD	O	11	VMOD	O
O	O	1577	1580	not	not	I-VP	RB	O	32	VMOD	O
O	O	1581	1587	affect	affect	I-VP	VB	O	32	VC	O
T15	B-Protein	1588	1592	SV40	SV40	B-NP	NN	B-protein	34	OBJ	B-protein
T15	I-Protein	1593	1601	promoter	promoter	I-NP	NN	I-protein	38	NMOD	I-protein
T15	I-Protein	1602	1610	specific	specific	I-NP	JJ	I-protein	38	NMOD	I-protein
T15	I-Protein	1611	1618	protein	protein	I-NP	NN	I-protein	35	NMOD	I-protein
T15	I-Protein	1618	1619	-	-	B-NP	HYPH	O	35	P	O
T15	I-Protein	1619	1620	1	1	I-NP	CD	O	35	NMOD	O
O	O	1620	1621	.	.	O	.	O	11	P	O

O	O	1622	1624	We	We	B-NP	PRP	O	2	SUB	O
O	O	1625	1633	conclude	conclude	B-VP	VBP	O	0	ROOT	O
O	O	1634	1638	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	1639	1649	engagement	engagement	B-NP	NN	O	9	SUB	O
O	O	1650	1652	of	of	B-PP	IN	O	4	NMOD	O
O	O	1653	1657	CD15	CD15	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	1658	1660	on	on	B-PP	IN	O	4	NMOD	O
O	O	1661	1670	monocytes	monocyte	B-NP	NNS	B-cell_type	7	PMOD	B-cell_type
O	O	1671	1678	results	result	B-VP	VBZ	O	3	SBAR	O
O	O	1679	1681	in	in	B-PP	IN	O	9	VMOD	O
O	O	1682	1690	monocyte	monocyte	B-NP	NN	O	12	NMOD	O
O	O	1691	1701	activation	activation	I-NP	NN	O	10	PMOD	O
O	O	1701	1702	.	.	O	.	O	2	P	O

O	O	1703	1705	In	In	B-PP	IN	O	12	VMOD	O
O	O	1706	1714	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	1715	1717	to	to	B-PP	TO	O	2	NMOD	O
O	O	1718	1721	its	its	B-NP	PRP$	O	9	NMOD	O
O	O	1722	1726	well	well	I-NP	RB	O	7	AMOD	O
O	O	1726	1727	-	-	I-NP	HYPH	O	5	AMOD	O
O	O	1727	1737	recognized	recognize	I-NP	VBN	O	9	NMOD	O
O	O	1738	1746	adhesive	adhesive	I-NP	JJ	O	9	NMOD	O
O	O	1747	1751	role	role	I-NP	NN	O	3	PMOD	O
O	O	1751	1752	,	,	O	,	O	12	P	O
O	O	1753	1757	CD15	CD15	B-NP	NN	B-protein	12	SUB	B-protein
O	O	1758	1761	may	may	B-VP	MD	O	0	ROOT	O
O	O	1762	1770	function	function	I-VP	VB	O	12	VC	O
O	O	1771	1773	as	as	B-PP	IN	O	13	VMOD	O
O	O	1774	1776	an	an	B-NP	DT	O	18	NMOD	O
O	O	1777	1786	important	important	I-NP	JJ	O	18	NMOD	O
O	O	1787	1796	signaling	signal	I-NP	VBG	O	18	NMOD	O
O	O	1797	1805	molecule	molecule	I-NP	NN	O	14	PMOD	O
O	O	1806	1813	capable	capable	B-ADJP	JJ	O	18	NMOD	O
O	O	1814	1816	of	of	B-PP	IN	O	19	AMOD	O
O	O	1817	1827	initiating	initiate	B-VP	VBG	O	20	PMOD	O
O	O	1828	1843	proinflammatory	proinflammatory	B-NP	JJ	O	23	NMOD	O
O	O	1844	1850	events	event	I-NP	NNS	O	21	OBJ	O
O	O	1851	1853	in	in	B-PP	IN	O	23	NMOD	O
O	O	1854	1863	monocytes	monocyte	B-NP	NNS	B-cell_type	24	PMOD	B-cell_type
O	O	1864	1868	that	that	B-NP	WDT	O	25	NMOD	O
O	O	1869	1873	come	come	B-VP	VBP	O	26	SBAR	O
O	O	1874	1878	into	into	B-PP	IN	O	27	VMOD	O
O	O	1879	1886	contact	contact	B-NP	NN	O	28	PMOD	O
O	O	1887	1891	with	with	B-PP	IN	O	29	NMOD	O
O	O	1892	1901	activated	activate	B-NP	VBN	O	32	NMOD	O
O	O	1902	1913	endothelium	endothelium	I-NP	NN	O	30	PMOD	O
O	O	1913	1914	.	.	O	.	O	12	P	O
